Clinical Trials Logo

Adenoma, Bile Duct clinical trials

View clinical trials related to Adenoma, Bile Duct.

Filter by:
  • None
  • Page 1

NCT ID: NCT05148143 Recruiting - Cholangioadenoma Clinical Trials

RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor

RALOXBTC
Start date: June 1, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study was to explore the safety and efficacy of raltitrexed combined with oxaplatin as second line treatment for advanced malignant biliary system tumor.

NCT ID: NCT03951324 Enrolling by invitation - Cholangiocarcinoma Clinical Trials

Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study

VLE-IOV
Start date: May 10, 2019
Phase:
Study type: Observational

The purpose of this study is to assess the interobserver agreement (IOV) for pancreatico-biliary Volumetric Laser Endomicroscopy (VLE) de-identified clips using the new VLE criteria. This is an Interobserver study to validate VLE criteria for indeterminate biliary and pancreatic duct strictures and evaluate impact on clinical management.

NCT ID: NCT03270046 Completed - Adenoma, Bile Duct Clinical Trials

The Effects of An Addition of Water Enema to PEG for Colon Preparation

Start date: August 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the preparation quality by using Ottawa Bowel Preparation Scale between the standard PEG preparation and the addition of water enema in participants scheduled for CRC screening

NCT ID: NCT02825524 Completed - Adenoma, Bile Duct Clinical Trials

Destruction of Residual Endo-biliary Dysplastic Buds After Endoscopic Ampullectomy

endoHPB
Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the efficacy and morbidity of biliairy radiofrequency ablation for the treatment of dysplastic endobiliairy residual lesions (low-grade dysplasia or high-grade dysplasia) after endoscopic ampullectomy for ampullary adenoma.